iCo Therapeutics Inc. and Satellos Bioscience Inc., announced business combination of iCo and Satellos. The parties expect to complete an amalgamation of iCo and Satellos, with the resulting entity named "Satellos Bioscience Inc." operating in the life sciences industry.
iCo Therapeutics Inc. Agrees to a Business Combination with Satellos Bioscience Inc.
Previous
Previous
OBIO’s Women in the Business of Health Science Bootcamp Participants are Ready to Enter the Health Science Industry
Next
Next